|
Veterinary
Scientist Clinton Jones wants to understand the genetic circuitry
that allows a herpes virus to wait silently in animal or human cells,
then reactivate and repeatedly attack its host and spread infection.
His
University of Nebraska research into genes controlling this latency
is on the leading edge of breakthrough theories about how herpes
viruses cause disease and perpetuate themselves in humans and cattle.
These theories offer hope for new herpes vaccines and treatments.
Jones
works with two viruses, Bovine Herpes Virus-1 (BHV-1) and the closely-related
human herpes simplex virus type 1 (HSV-1). Both cause infection
by traveling to neurons, specialized cells that transmit messages
to the brain. Viruses replicate by commandeering the genetic machinery
of host cells, usually killing cells and causing disease symptoms.
When BHV-1 or HSV-1 infects a neuron, the virus often shuts off,
entering latency and allowing the neuron to survive.
Latency
may be the key to new herpes virus treatments and vaccines. Latency
helps the virus survive by keeping infected host cells alive, allowing
the virus to periodically reactivate and infect other hosts, Jones
said.
How
and why herpes viruses become latent is the focus of Jones' Institute
of Agriculture and Natural Resources research.
"If
you could prevent a virus from becoming latent, you could make better
vaccines and slow down or inhibit virus transmission," he said.
Cattle
with BHV-1 may suffer bovine respiratory complex, eye disease, miscarriage
and, occasionally, lethal encephalitis, problems that cost cattle
producers more than $500 million annually. Available vaccines can
cause abortion and disease in calves and don't prevent latency,
so vaccinated cattle may spread disease to calves.
HSV-1
can infect people's nervous systems, respiratory tracts and gastrointestinal
tracts, is a serious venereal disease and is the leading cause of
infectious corneal blindness.
"Corneal
blindness is caused by the virus reactivating from latency and reinfecting
the eye over and over," Jones said. "If we could block
latency, we could literally stop this disease."
In
his early BHV-1 work, Jones discovered that the latency-related
gene encodes a latency-related protein. The protein is found in
neurons during latency. He thought this protein might help regulate
latency. Independent research revealed a similar gene in the human
herpes virus, but it's not known whether this gene encodes a protein.
In 1996, at the same time Jones was exploring the "how"
of latency, a relatively new concept called programmed cell death
(PCD) emerged from cell biology research and offered clues to "why"
this was important for latency.
PCD
is a natural function for many cells, which must die and be replaced
as organisms grow. Neurons are different, Jones said.
"Very
early in mammalian development neurons stop growing. It doesn't
make sense for neurons to undergo PCD because they can't be replaced,"
Jones said.
Jones
and others showed that infecting cultured cells or calves with BHV-1
can induce PCD. Jones' recent research revealed the BHV-1 latency-related
protein he discovered earlier may promote latency by stopping programmed
cell death in neurons.
"We
are the first to demonstrate that latency gene products inhibit
cell death," Jones said. "We believe this prevents the
virus from destroying its site for latency and so helps perpetuate
the viruses in their natural hosts."
The
latency-related gene acts like a switch. When it's on, the virus
produces the protein, PCD is inhibited, and the host cell and virus
survive. Finding a way to switch the gene off could be a way to
treat and inhibit the spread of viral diseases.
"We
know that the latency-related genes inhibit PCD, but we don't know
how. We are studying that now," Jones said.
Two
USDA competitive grants, a competitive grant from the Elsa U. Pardee
Foundation and NU's Center for Biotechnology help fund this research.
Monica Norby
|